Boundless Bio (BOLD) Other financing activities (2023 - 2025)
Boundless Bio (BOLD) posted quarterly Other financing activities of $24000.0 for Q4 2025, up 100.03% year-over-year from $11998.5 in Q4 2024, and up 100.03% quarter-over-quarter from -$92.9 million in Q4 2024.
Boundless Bio (BOLD) Other financing activities (2023 - 2025) Analysis & Trends
Boundless Bio (BOLD) has reported Other financing activities for 3 consecutive years, with $24000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities rose 100.03% year-over-year to $24000.0; the TTM figure through Dec 2025 stood at -$92.9 million (down 149961.29% YoY), while the FY2025 annual figure was $141000.0, up 127.42% from the prior year.
- Other financing activities grew to $24000.0 in Q4 2025 per BOLD's latest filing, from -$92.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $92.9 million in Q2 2024 and bottomed at -$92.9 million in Q4 2024.
- Historically, Other financing activities has averaged $33500.0 across 3 years, with a median of $35000.0 in 2023.
- On a YoY basis, Other financing activities climbed as much as 357365.38% in 2024 and fell as far as 238402.56% in 2024.
- Boundless Bio's Other financing activities stood at $39000.0 in 2023, then slumped by 238402.56% to -$92.9 million in 2024, then soared by 100.03% to $24000.0 in 2025.
- Business Quant data shows BOLD's Other financing activities at $24000.0 in Q4 2025, -$92.9 million in Q4 2024, and $92.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2024 | -92.94 Mn |
| Dec 31, 2024 | -92.94 Mn |
| Jun 30, 2024 | 92.94 Mn |
| Jun 30, 2024 | 92.94 Mn |
| Mar 31, 2024 | 59,000.00 |
| Mar 31, 2024 | 59,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | 86,000.00 |
| Sep 30, 2023 | 86,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 26,000.00 |
| Mar 31, 2023 | 31,000.00 |
| Mar 31, 2023 | 31,000.00 |